These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35898886)
1. Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram. Qi J; Gao A; Ma X; Song Y; Zhao G; Bai J; Gao E; Zhao K; Wen B; Zhang Y; Cheng J Front Oncol; 2022; 12():937050. PubMed ID: 35898886 [TBL] [Abstract][Full Text] [Related]
2. MRI-Based radiomics nomogram for differentiation of benign and malignant lesions of the parotid gland. Zheng YM; Li J; Liu S; Cui JF; Zhan JF; Pang J; Zhou RZ; Li XL; Dong C Eur Radiol; 2021 Jun; 31(6):4042-4052. PubMed ID: 33211145 [TBL] [Abstract][Full Text] [Related]
3. The Role of an MRI-Based Radiomic Signature in Predicting Malignancy of Parotid Gland Tumors. Muntean DD; Dudea SM; Băciuț M; Dinu C; Stoia S; Solomon C; Csaba C; Rusu GM; Lenghel LM Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444429 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of CT-based radiomics nomogram for the classification of benign parotid gland tumors. Zheng M; Chen Q; Ge Y; Yang L; Tian Y; Liu C; Wang P; Deng K Med Phys; 2023 Feb; 50(2):947-957. PubMed ID: 36273307 [TBL] [Abstract][Full Text] [Related]
5. CT-based radiomics with various classifiers for histological differentiation of parotid gland tumors. Lu Y; Liu H; Liu Q; Wang S; Zhu Z; Qiu J; Xing W Front Oncol; 2023; 13():1118351. PubMed ID: 36969052 [TBL] [Abstract][Full Text] [Related]
6. The value of T1- and FST2-Weighted-based radiomics nomogram in differentiating pleomorphic adenoma and Warthin tumor. Sun H; Sun Z; Wang W; Cha X; Jiang Q; Wang X; Li Q; Liu S; Liu H; Chen Q; Yuan W; Xiao Y Transl Oncol; 2024 Nov; 49():102087. PubMed ID: 39159554 [TBL] [Abstract][Full Text] [Related]
7. Distinguishing Parotid Polymorphic Adenoma and Warthin Tumor Based on the CT Radiomics Nomogram: A Multicenter Study. Feng B; Wang Z; Cui J; Li J; Xu H; Yu D; Zeng Q; Xiu J Acad Radiol; 2023 Apr; 30(4):717-726. PubMed ID: 35953356 [TBL] [Abstract][Full Text] [Related]
8. Apparent Diffusion Coefficient Map-Based Radiomics Features for Differential Diagnosis of Pleomorphic Adenomas and Warthin Tumors From Malignant Tumors. Wen B; Zhang Z; Zhu J; Liu L; Li Y; Huang H; Zhang Y; Cheng J Front Oncol; 2022; 12():830496. PubMed ID: 35747827 [TBL] [Abstract][Full Text] [Related]
9. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland. Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128 [TBL] [Abstract][Full Text] [Related]
10. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid. Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of an MRI-based radiomics nomogram for distinguishing Warthin's tumour from pleomorphic adenomas of the parotid gland. Zheng YM; Chen J; Xu Q; Zhao WH; Wang XF; Yuan MG; Liu ZJ; Wu ZJ; Dong C Dentomaxillofac Radiol; 2021 Oct; 50(7):20210023. PubMed ID: 33950705 [TBL] [Abstract][Full Text] [Related]
12. A nomogram based on clinical information, conventional ultrasound and radiomics improves prediction of malignant parotid gland lesions. Li Q; Jiang T; Zhang C; Zhang Y; Huang Z; Zhou H; Huang P Cancer Lett; 2022 Feb; 527():107-114. PubMed ID: 34929334 [TBL] [Abstract][Full Text] [Related]
13. A deep learning model for the differential diagnosis of benign and malignant salivary gland tumors based on ultrasound imaging and clinical data. Zhang G; Zhu L; Huang R; Xu Y; Lu X; Chen Y; Li C; Lei Y; Luo X; Li Z; Yi S; He J; Zheng C Quant Imaging Med Surg; 2023 May; 13(5):2989-3000. PubMed ID: 37179911 [TBL] [Abstract][Full Text] [Related]
14. Different MRI-based radiomics models for differentiating misdiagnosed or ambiguous pleomorphic adenoma and Warthin tumor of the parotid gland: a multicenter study. Yang J; Bi Q; Jin Y; Yang Y; Du J; Zhang H; Wu K Front Oncol; 2024; 14():1392343. PubMed ID: 38939335 [TBL] [Abstract][Full Text] [Related]
15. MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes. Xiao G; Hu YC; Ren JL; Qin P; Han JC; Qu XY; Rong WC; Yan WQ; Tian Q; Han Y; Wang WP; Wang SM; Ma J; Wang W; Cui GB Eur Radiol; 2021 Jan; 31(1):447-457. PubMed ID: 32700020 [TBL] [Abstract][Full Text] [Related]
16. A CT-based radiomics nomogram for differentiation of lympho-associated benign and malignant lesions of the parotid gland. Zheng YM; Xu WJ; Hao DP; Liu XJ; Gao CP; Tang GZ; Li J; Wang HX; Dong C Eur Radiol; 2021 May; 31(5):2886-2895. PubMed ID: 33123791 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images. Faggioni L; Gabelloni M; De Vietro F; Frey J; Mendola V; Cavallero D; Borgheresi R; Tumminello L; Shortrede J; Morganti R; Seccia V; Coppola F; Cioni D; Neri E Eur J Radiol Open; 2022; 9():100429. PubMed ID: 35757232 [TBL] [Abstract][Full Text] [Related]
18. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients. Li C; Yin J Front Oncol; 2021; 11():671354. PubMed ID: 34041033 [TBL] [Abstract][Full Text] [Related]
19. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging. Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of benign and malignant parotid gland tumors based on the fusion of radiomics and deep learning features on ultrasound images. Wang Y; Gao J; Yin Z; Wen Y; Sun M; Han R Front Oncol; 2024; 14():1384105. PubMed ID: 38803533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]